Strax

Autospela

NCCN Guidelines for HR+ HER2 Metastatic Breast Cancer

2 Visningar • 07/03/23
Dela med sig
Bädda in
administrator
administrator
Prenumeranter
0

Debu Tripathy, MD, and Hatem Soliman, MD, reflect on the NCCN guideline criteria and patient factors that play into decision making for frontline therapy in hormone receptor–positive metastatic breast cancer.

Visa mer
0 Kommentarer sort Sortera efter
Facebook-kommentarer

Strax

Autospela